On May 27, Wuxi Municipal Party Secretary Du Xiaogang met with a delegation led by AstraZeneca Global Executive Vice President and Head of International Business Yin Sirui to discuss accelerating implementation of cooperation items agreed when Jiangsu provincial leaders met AstraZeneca Global Chief Executive Su Boke and other senior executives in March. Both sides said they will firmly follow the cooperation direction jointly set by the Jiangsu provincial committee and government and AstraZeneca

Aoyi Technology, a domestic non‑invasive BCI firm, has signed a strategic cooperation agreement with Weichuang Brain Science (02172.HK) to jointly develop an interventional brain‑computer interface (BCI) rehabilitation system. The design uses a minimally invasive endovascular route to deliver a signal‑collection stent to targeted brain regions without craniotomy. Decoded neural signals will be converted into motor control commands to drive a lightweight exoskeleton robot, aimed at assisting stroke and spinal‑cord injury patients and enabling closed‑loop neurofunctional rehabilitation. The partners plan to begin clinical trials within one year.

The Office of the U.S. Trade Representative (USTR) said the United States and Mexico will hold the second round of United States-Mexico-Canada Agreement (USMCA) talks in Washington on June 16-17, with a focus on agriculture and a "level playing field".